Dr Penny Kechagioglou, Consultant Clinical Oncologist, Chief Clinical Information Officer, deputy Chief Medical Officer UHCW & UKIHCA Health Coach, will talk about her own shift from conventional standard-of-care oncologist to health coach and advocate for Integrative Medicine.

Prof Robert Thomas, has recently taken on the role of Head of Integrative Oncology at the Royal London Hospital for Integrated Medicine (RLHIM) in addition to his NHS and private oncology practices in Cambridge and Bedfordshire. He has been gathering data on the cancer-related conditions they manage at the RLHIM and will share his insights and reflections on the impact and potential benefits of the different integrative approaches they use. 

Dr Jean-Lionel Bagot's presentation will highlight France’s first Integrative Oncology Day Hospital, now five years in operation as part of mainstream cancer care protocols in Strasbourg. He will present qualitative data on their unique therapeutic meal program, and patient perceptions of their complementary therapy consultations. He will also discuss the French Society of Integrative Oncology's work and highlight how therapeutic guidelines, for example those produced by the International Homeopathic Society for Supportive Care in Oncology, can ensure safety while increasing patient choice.

Dr Longo's studies explore whether fasting and fasting-mimicking diets can make cancer therapies potentially more effective and less toxic to patients. He will be presenting data gathered over a decade and a half and discussing the potential applications of his research alongside mainstream treatments.

Dr James Kinross, reader in colorectal surgery and a consultant surgeon at Imperial College London, where his research team are trying to engineer the microbiome to improve cancer therapy and reduce the adverse side effects of chemotherapy.

Physical activity in oncology has transcended its role in prevention, emerging as a vital component of cancer therapy with the potential to transform patient outcomes. Darryl Edwards will highlight the barriers for integrating physical activity into clinical practice and highlight practical, evidence-based approaches for therapeutic exercise across the continuum of cancer care.

Dr Wafaa will highlight the importance of understanding cancer dynamics and will discuss affordable and non-negotiable tests that she utilises.  She will also highlight key lifestyle changes, which are simple, affordable, and done at home, that are vital for controlling the cancer microenvironment and enhancing treatment success. 

Dr Sam Watts will explore the clinical and evidential synergy between the Western and Ayurvedic understanding of exceptional cancer survival, the mechanisms that are predictive of this state and how Ayurveda can provide a unified framework for the adoption of these mechanisms. 

Mistletoe therapy is a complementary treatment used in integrative oncology to support cancer patients by stimulating the immune system.  Dr Nasha Winters will highlight how mistletoe therapy is utilised in a holistic approach to cancer treatment, emphasizing its potential to reduce side effects of conventional treatments, such as chemotherapy, while promoting healing and vitality. 

The growing demand for integrative cancer care reveals gaps in current treatment protocols, with many people turning to unproven or harmful options due to insufficient information and support. Dr HariHaran Kuhan will highlight the potential benefits of Repurposed Medicines and other Metabolically Targeted Interventions. He will discuss difficulties in obtaining valid and reliable research data about these and other integrative options, and suggest some possible strategies to address this. He will also explore the potential benefits of collaborating with public health authorities to facilitate more representative patient populations and more robust research, and emphasise the need to establish reliable, accessible, evidence-based clinical services that incorporate what is already well-established and known about metabolic oncology. 

The panel will explore the transformative potential of psychedelic medicine in addressing the psychospiritual needs of cancer patients. By alleviating existential distress, end of life anxiety, and depression, psychedelics offer a unique pathway to emotional healing and a deeper sense of meaning. The discussion will cover current research, therapeutic applications, and real-world experiences, highlighting how these medicines, when used in the appropriate settings, and with skilled support, can help patients navigate their journey with greater peace, resilience, and connection.

Dr Jeffrey Rediger is an instructor in psychiatry at Harvard Medical School and medical director for the McLean SouthEast Adult Psychiatric Programmes and is the author of the New York Times best-seller 'Cured - The Remarkable Science and Stories of Spontaneous Healing and Recovery'.  By exploring the surprising stories of those who have recovered completely and unexpectedly from terminal illnesses, Dr Jeff Rediger reveals the immense power of our immune systems.